Stockreport

Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research

Agilent Technologies, Inc.  (A) 
Last agilent technologies, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
PDF New CRISPR-based Transcriptional Activation and Interference (a/i) Libraries SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies [Read more]